Ligand ID: GNT Drugbank ID: DB00674(Galantamine) Indication:For the treatment of mild to moderate dementia of the Alzheimer's type. Has also been investigated in patients with mild cognitive impairment who did not meet the diagnostic criteria for Alzheimer's disease. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 11 | ASP C 153GLY A 124GLU A 14SER A 10PHE C 150 | 1.66A | 18.77 | None | ||
![]() | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 2GLY A 138TYR A 126SER C 1TYR A 118 | 1.65A | 19.85 | None | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASP C 153GLY A 124GLU A 14SER A 10PHE C 150 | 1.68A | 18.98 | None | ||
![]() | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY D 2GLY B 138TYR B 126SER D 1TYR B 118 | 1.60A | 19.85 | None | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 833GLY A 841GLY A 839PHE A 428PHE A 429 | 1.74A | 19.48 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m71 | NSP8 (SARS-CoV-2) | 4 / 7 | TRP B 182GLN B 168TYR B 138ILE B 132 | 1.79A | 20.87 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 833GLY A 841GLY A 839PHE A 428PHE A 429 | 1.78A | 19.47 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A 574GLY A 548GLY A 550PHE A 592PHE B 855 | 1.76A | 17.69 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR C 495GLN C 506TYR C 508ILE C 418 | 1.62A | 10.73 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | GLN C 901TYR C 904TYR B1047ILE B 909 | 1.73A | 11.41 | None | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.62A | 13.78 | NoneNoneNoneNoneAPR A 201 (-3.4A) | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.63A | 14.18 | NoneNoneNoneNoneAPR A 201 (-3.4A) | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.64A | 14.18 | NoneNoneNoneNoneAPR A 201 (-3.4A) | ||
![]() | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAINSPIKE PROTEIN S1 (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY H 97GLY C 381TYR L 32SER H 99PHE C 515 | 1.79A | 14.55 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.72A | NoneNoneNoneNoneAMP A 201 ( 4.3A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | ASP B 105GLY B 79GLY B 78GLY B 97PHE B 132 | 1.58A | NoneNoneNoneNoneMES B 201 ( 3.4A) | |||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | GLN C 237TYR C 213TYR C 310ILE C 314 | 1.58A | 23.01 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | GLN A 237TYR A 213TYR A 310ILE A 314 | 1.62A | 23.01 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | GLN B 237TYR B 213TYR B 310ILE B 314 | 1.45A | 23.01 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.65A | NoneNoneNoneNoneMES A 201 (-2.5A) | |||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.63A | 13.78 | NoneNoneNoneNoneMES A 201 (-2.5A) | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.64A | 14.18 | NoneNoneNoneNoneMES A 201 (-2.5A) | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.69A | None | |||
![]() | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 283GLY A 282GLY A 301SER A 315PHE A 336 | 1.52A | 13.89 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | ASP A 309GLY A 283GLY A 282GLY A 301PHE A 336 | 1.66A | None | |||
![]() | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY E 284GLY F 316PHE F 315TYR E 333PHE F 314 | 1.75A | 11.21 | None | ||
![]() | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY D 284GLY C 316PHE C 315TYR D 333PHE C 314 | 1.78A | 11.21 | None | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.66A | 17.66 | NoneNoneNoneNoneAPR A 201 (-3.1A) | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP D 105GLY D 79GLY D 78GLY D 97PHE D 132 | 1.63A | NoneNoneNoneNoneAPR D 201 (-3.5A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.67A | NoneNoneNoneNoneAPR A 201 (-3.1A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP C 105GLY C 79GLY C 78GLY C 97PHE C 132 | 1.57A | NoneNoneNoneNoneAPR C 201 (-3.5A) | |||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP D 105GLY D 79GLY D 78GLY D 97PHE D 132 | 1.62A | 17.66 | NoneNoneNoneNoneAPR D 201 (-3.5A) | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP D 105GLY D 79GLY D 78GLY D 97PHE D 132 | 1.63A | 17.66 | NoneNoneNoneNoneAPR D 201 (-3.5A) | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP C 105GLY C 79GLY C 78GLY C 97PHE C 132 | 1.66A | 17.66 | NoneNoneNoneNoneAPR C 201 (-3.5A) | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP B 105GLY B 79GLY B 78GLY B 97PHE B 132 | 1.64A | 17.66 | NoneNoneNoneNoneAPR B 201 (-3.6A) | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.65A | 17.66 | NoneNoneNoneNoneAPR A 201 (-3.1A) | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 7 | GLN A 237TYR A 213TYR A 310ILE A 314 | 1.56A | 22.80 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 4 / 7 | GLN A 133TYR A 136TYR A 154ILE A 151 | 1.73A | 22.80 | None | ||
![]() | 1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 11 | ASP A 153GLY B 124GLU B 14SER B 10PHE A 150 | 1.66A | 18.77 | None | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASP A 153GLY B 124GLU B 14SER B 10PHE A 150 | 1.63A | 18.98 | None | ||
![]() | 1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | ASP A 153GLY B 124GLU B 14SER B 10PHE A 150 | 1.61A | 18.77 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6yla | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY B 101GLY A 381TYR C 38PHE A 515PHE A 392 | 1.51A | None | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY B 101GLY A 381PHE A 429PHE A 392PHE A 515 | 1.78A | None | |||
![]() | 4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE) | 6yla | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY B 101GLY A 381TYR C 38PHE A 515PHE A 392 | 1.45A | 18.05 | None | ||
![]() | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) | 6yla | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY B 101GLY A 381TYR C 38PHE A 515PHE A 392 | 1.48A | 18.05 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508GLN E 506TYR E 505ILE E 418 | 1.76A | 20.49 | DMS E 902 (-4.0A)NoneNoneNone | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6yla | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY B 101GLY A 381TYR C 38PHE A 515PHE A 392 | 1.50A | 18.15 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 508GLN A 506TYR A 505ILE A 418 | 1.57A | 20.49 | DMS A 903 (-3.5A)NoneNoneNone | ||
![]() | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) | 6ym0 | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY H 101GLY E 381TYR L 38PHE E 515PHE E 392 | 1.63A | 18.05 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508GLN E 506TYR E 505ILE E 418 | 1.55A | 20.49 | None | ||
![]() | 4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE) | 6ym0 | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY H 101GLY E 381TYR L 38PHE E 515PHE E 392 | 1.60A | 18.05 | None | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6ym0 | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY H 101GLY E 381TYR L 38PHE E 515PHE E 392 | 1.65A | 18.15 | None | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 6ym0 | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY H 101GLY E 381PHE E 429PHE E 392PHE E 515 | 1.72A | 18.13 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ym0 | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY H 101GLY E 381TYR L 38PHE E 515PHE E 392 | 1.64A | None | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ym0 | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | GLY H 101GLY E 381PHE E 429PHE E 392PHE E 515 | 1.66A | None | |||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR E 508GLN E 506TYR E 505ILE E 418 | 1.76A | 20.17 | None | ||
![]() | 2PH9_A_GNTA301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | TYR A 508GLN A 506TYR A 505ILE A 418 | 1.77A | 20.17 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.58A | NoneNoneNoneEDO A 202 ( 4.9A)EDO A 202 (-3.9A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP B 105GLY B 79GLY B 78GLY B 97PHE B 132 | 1.66A | None | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP E 105GLY E 79GLY E 78GLY E 97PHE E 132 | 1.57A | NoneEPE E 203 (-3.3A)NoneNoneEPE E 202 (-3.2A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP D 105GLY D 79GLY D 78GLY D 97PHE D 132 | 1.62A | NoneNoneNoneNoneEDO D 205 ( 3.6A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP C 105GLY C 79GLY C 78GLY C 97PHE C 132 | 1.69A | NoneEPE C 202 (-3.4A)NoneNoneNone | |||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP E 105GLY E 79GLY E 78GLY E 97PHE E 132 | 1.66A | 16.99 | NoneEPE E 203 (-3.3A)NoneNoneEPE E 202 (-3.2A) | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.57A | NoneNoneNoneNoneAPR A 201 (-3.7A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP E 105GLY E 79GLY E 78GLY E 97PHE E 132 | 1.59A | NoneNoneNoneNoneAPR E 201 (-3.5A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP D 105GLY D 79GLY D 78GLY D 97PHE D 132 | 1.61A | EDO A 206 ( 4.6A)EDO D 203 (-3.1A)NoneNoneAPR D 201 (-3.3A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP B 105GLY B 79GLY B 78GLY B 97PHE B 132 | 1.59A | NoneNoneNoneNoneAPR B 201 (-3.5A) | |||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP D 105GLY D 79GLY D 78GLY D 97PHE D 132 | 1.69A | 16.99 | EDO A 206 ( 4.6A)EDO D 203 (-3.1A)NoneNoneAPR D 201 (-3.3A) | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP E 105GLY E 79GLY E 78GLY E 97PHE E 132 | 1.68A | 16.99 | NoneNoneNoneNoneAPR E 201 (-3.5A) | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP C 105GLY C 79GLY C 78GLY C 97PHE C 132 | 1.60A | NoneNoneNoneNoneAPR C 201 (-3.5A) | |||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP C 105GLY C 79GLY C 78GLY C 97PHE C 132 | 1.64A | 16.99 | NoneNoneNoneNoneMES C 201 (-3.6A) | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP B 105GLY B 79GLY B 78GLY B 97PHE B 132 | 1.68A | 16.99 | None | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP C 105GLY C 79GLY C 78GLY C 97PHE C 132 | 1.64A | 16.99 | NoneNoneNoneNoneMES C 201 (-3.6A) | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP B 105GLY B 79GLY B 78GLY B 97PHE B 132 | 1.67A | 16.99 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.57A | NoneEDO A 204 (-3.6A)NoneNoneMES A 201 (-3.5A) | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP B 105GLY B 79GLY B 78GLY B 97PHE B 132 | 1.68A | None | |||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.65A | 16.99 | NoneEDO A 204 (-3.6A)NoneNoneMES A 201 (-3.5A) | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP C 105GLY C 79GLY C 78GLY C 97PHE C 132 | 1.59A | NoneNoneNoneNoneMES C 201 (-3.6A) | |||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASP A 105GLY A 79GLY A 78GLY A 97PHE A 132 | 1.65A | 16.99 | NoneEDO A 204 (-3.6A)NoneNoneMES A 201 (-3.5A) | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 833GLY A 841GLY A 839PHE A 428PHE A 429 | 1.66A | 19.48 | None | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.59A | 19.48 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.63A | None | |||
![]() | 1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 10 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.73A | 19.47 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 833GLY A 841GLY A 839PHE A 428PHE A 429 | 1.69A | None | |||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.62A | 19.47 | None | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.62A | 19.62 | None | ||
![]() | 1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 10 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.77A | 19.62 | None | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.63A | None | |||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.59A | 19.58 | None | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 833GLY A 841GLY A 839PHE A 428PHE A 429 | 1.76A | 19.58 | None | ||
![]() | 1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 10 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.79A | 19.62 | U P 18 ( 3.9A)NoneNoneNoneNone | ||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 833GLY A 841GLY A 839PHE A 428PHE A 429 | 1.65A | 19.58 | None | ||
![]() | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.66A | 19.62 | U P 18 ( 3.9A)NoneNoneNoneNone | ||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 833GLY A 841GLY A 839PHE A 428PHE A 429 | 1.69A | None | |||
![]() | 1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.66A | U P 18 ( 3.9A)NoneNoneNoneNone | |||
![]() | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ASP A 865GLY A 839GLY A 841TYR A 884PHE A 859 | 1.63A | 19.58 | U P 18 ( 3.9A)NoneNoneNoneNone |